After removing the study from the analysis, the impact of heterogeneity was reduced to 16.8% and the difference in CSF DJ-1 levels between PD and MSA patients appeared (SMD = 1.05, 95% CI: 0.67 to 1.42) (Figure 6). The gene discussed is PARK7; the disease is Parkinson disease.